Pivotal ADAPT SERON results and interim ADAPT Jr data showcase VYVGART’s potential to treat broad set of myasthenia gravis patientsReal-world…
BERLIN, Oct. 15, 2025 (GLOBE NEWSWIRE) -- Vara announced today it received a new CE certificate for its new breast-imaging…
SOUTHAMPTON, Pa., Oct. 14, 2025 (GLOBE NEWSWIRE) -- Environmental Tectonics Corporation (OTCID: ETCC) (“ETC” or the “Company”) today reported its…
October 14, 2025 10:00 ET | Source: Silberstein & Miklos, P.C. Bronx, New York , Oct. 14, 2025 (GLOBE NEWSWIRE)…
Criminal IP at Booth J30 | Sands Expo Singapore | October 21 – 23, 2025TORRANCE, Calif., Oct. 14, 2025 (GLOBE…
October 14, 2025 08:05 ET | Source: Candel Therapeutics NEEDHAM, Mass., Oct. 14, 2025 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc.…
New Offerings Bring Millions Affordable Healthcare Solutions During Open Enrollment Season October 14, 2025 08:00 ET | Source: HealthEquity, Inc.…
SINGAPORE, Oct. 14, 2025 (GLOBE NEWSWIRE) -- CytoMed Therapeutics Limited (NASDAQ: GDTC) (“CytoMed” or “Company”), a Singapore-based clinical stage biopharmaceutical…
- Plenary session oral presentation: Friday, October 24 10:00 -11:40 a.m. ET - Poster presentation on preclinical evaluation of petosemtamab…
RADNOR, Pa. and SOUTH SAN FRANCISCO, Calif., Oct. 13, 2025 (GLOBE NEWSWIRE) -- Quanta Therapeutics, a privately-held clinical-stage biopharmaceutical company…